UPPSALA, Sweden, May 27, 2018 /PRNewswire/ — Beactica, the Swedish drug discovery company with world-leading expertise in molecular interactions, today announced that it has signed a three-year extension of its master services agreement with Sanofi. The agreement outlines the legal terms…
